(Press-News.org) Measurements with a miniature camera inside the coronary arteries can accurately predict whether someone will suffer a recurrent heart attack. Until now, interpreting these images was so complex that only specialized laboratories could perform it. A new study from Radboud university medical center shows that AI can reliably take over this analysis and rapidly assess arteries for weak spots.
A heart attack occurs when a coronary artery, which supplies the heart with blood, is blocked by a blood clot. This can occur when atherosclerosis causes artery narrowing, resulting in the heart receiving too little oxygen. Treatment typically involves angioplasty, where a cardiologist widens the artery with a small balloon, usually followed by the placement of a tiny tube, called a stent. In the Netherlands, this procedure is performed about 40,000 times per year.
Predicting recurring events
Nevertheless, about fifteen percent of patients who suffer from a heart attack experience another event within two years. To better identify vulnerable spots within the artery that can trigger new infarctions, technical physician Jos Thannhauser and physician Rick Volleberg of Radboudumc, together with their team, conducted a study. They analyzed the coronary arteries of 438 patients using a miniature camera and specially developed AI, and followed these patients for two years.
The study shows that AI detects vulnerable spots in the arterial wall just as well as specialized laboratories—the international gold standard—and even predicts new infarctions or death within two years more accurately. What does this mean for patients? Volleberg explains: ‘If we know who has high-risk plaques and where they are located, we may in the future be able to tailor medication or even place preventive stents.’
Looking inside the artery wall
The miniature camera uses a technique called optical coherence tomography (OCT). Inserted through the arm into the bloodstream, it captures images of arteries using near-infrared light, visualizing the vessel wall at microscopic resolution.
‘This technique is already used in clinical practice to guide angioplasty and to check whether a stent has been placed correctly’, explains Thannhauser. ‘It has been shown that OCT reduces the risk of new infarctions and complications. But in those cases, physicians only look at a very small part of an artery—the site of the infarction. Our study shows that this technique, combined with AI, has much greater potential to map entire vessels.’
Towards clinical application with AI
‘One of the challenges with this technique is that it is extremely difficult for physicians to interpret OCT images’, says Thannhauser. That’s not surprising—each procedure produces hundreds of images. Even assessing just the stent placement is challenging. Analyzing entire coronary arteries produces far too many images to evaluate manually. ‘Currently, only a handful of specialized labs can interpret these images, and even they cannot review everything. Moreover, it’s too expensive and labor-intensive to implement this manually in routine clinical care.’
That is why Thannhauser’s team developed AI that can analyze all images reliably and much faster than humans. ‘AI can already assist physicians during stent placement with OCT’, Thannhauser explains. ‘Thanks to our AI, we are now a step closer to scanning entire coronary arteries for vulnerable spots in clinical practice. I do expect, however, that it will take a number of years before this becomes reality.’
The CARA Lab
Thannhauser leads the CARA Lab—Cardiology lab with Abbott, Radboudumc and Amsterdam UMC. Together with Niels van Royen (Radboudumc) and Ivana Išgum (Amsterdam UMC), his team received a grant from the Dutch Research Council (NWO). The present study is one of its results.
END
Combination of mini-camera and AI predicts recurrent heart attack
AI rapidly assesses coronary arteries for vulnerable spots
2025-09-01
ELSE PRESS RELEASES FROM THIS DATE:
Study Reveals Details of Overactive Immune System in Patients with Chronic Fatigue Syndrome (ME/CFS)
2025-09-01
Patients with chronic fatigue syndrome/myalgic encephalomyelitis (ME/CFS) have heightened innate immune responses to bacteria, viruses and fungi. While these responses are essential to fight infection, they can cause damage when unchecked. Led by researchers at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health with a multicenter team of leading ME/CFS researchers, the new study reveals molecular-level details into the syndrome’s lasting effects on inflammation and immune response that could inform the development of targeted therapeutic interventions to ...
UTSA and UT Health San Antonio complete merger to become The University of Texas at San Antonio
2025-09-01
SAN ANTONIO, Sept. 1, 2025 – UTSA and The University of Texas Health Science Center at San Antonio (UT Health San Antonio) today merged to form The University of Texas at San Antonio (UT San Antonio), a premier global university that is deeply committed to making lives better for the communities it serves. As a merged institution, UT San Antonio now ranks as the third-largest public research university in Texas according to annual research expenditures, behind only Texas A&M University and the University of Texas at Austin.
UT San Antonio’s comprehensive enterprise now includes approximately 40,000 students, 17,000 employees and more than $486 million in annual ...
Helicobacter pylori screening after acute myocardial infarction
2025-09-01
About The Study: Among unselected patients with acute myocardial infarction, routine H pylori screening did not significantly reduce the risk of upper gastrointestinal bleeding.
Corresponding Author: To contact the corresponding author, Robin Hofmann, MD, PhD, email robin.hofmann@ki.se.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Embed this link to provide your readers ...
Solar Orbiter traces superfast electrons back to Sun
2025-09-01
The European Space Agency-led Solar Orbiter mission has split the flood of energetic particles flung out into space from the Sun into two groups, tracing each back to a different kind of outburst from our star.
The Sun is the most energetic particle accelerator in the Solar System. It whips up electrons to nearly the speed of light and flings them out into space, flooding the Solar System with so-called ‘Solar Energetic Electrons’ (SEEs).
Researchers have now used Solar Orbiter to pinpoint the source of these energetic electrons and trace what we see out in space back to what’s actually ...
GaN-based electron beam technology from Nagoya University startup poised to overcome critical semiconductor manufacturing challenges at KIOXIA
2025-09-01
NAGOYA, Japan — In late September 2025, KIOXIA Iwate Corporation (Koichiro Shibayama CEO) will begin evaluating a GaN-based e-beam technology developed through joint research between Photo electron Soul Inc. (PeS; Takayuki Suzuki CEO), a Nagoya University startup, and the Amano–Honda Laboratory at Nagoya University.
PeS has developed a next-generation electron gun specialized for GaN (gallium nitride) photocathodes and has demonstrated its effectiveness for semiconductor inspection and metrology (I&M), enabling electron microscopy of nanoscale transistors and high-aspect-ratio structures.
These ...
Circle versus rectangle: Finding ‘Earth 2.0’ may be easier using a new telescope shape
2025-09-01
by Prof Heidi Newberg
The Earth supports the only known life in the universe, all of it depending heavily on the presence of liquid water to facilitate chemical reactions. While single-celled life has existed almost as long as the Earth itself, it took roughly three billion years for multicellular life to form. Human life has existed for less than one 10 thousandth of the age of the Earth.
All of this suggests that life might be common on planets that support liquid water, but it might be uncommon to find life that studies the universe and seeks to travel ...
Metformin changes blood metal levels in humans
2025-09-01
The widely used diabetes drug metformin changes blood metal levels in humans. The Kobe University study is an important step in understanding the drug’s many actions and designing better ones in the future.
Metformin is the most widely prescribed diabetes drug in the world. Apart from lowering blood sugar levels, it is also known to have a broad range of beneficial side effects such as against tumors, inflammations and atherosclerosis. However, although it has been used for more than 60 years ...
Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation
2025-08-31
About The Study: Among patients without documented atrial arrhythmia recurrence after catheter ablation for atrial fibrillation, discontinuing oral anticoagulant therapy resulted in a lower risk for the composite outcome of stroke, systemic embolism, and major bleeding vs continuing direct oral anticoagulant therapy.
Corresponding Author: To contact the corresponding author, Boyoung Joung, MD, email cby6908@yuhs.ac.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
Editor’s Note: Please see the article for additional information, including other authors, author contributions and ...
Fractional flow reserve–guided complete vs culprit-only revascularization in non–ST-elevation myocardial infarction and multivessel disease
2025-08-31
About The Study: Fractional flow reserve-guided complete revascularization during the index procedure resulted in a significant reduction in the composite of all-cause death, nonfatal myocardial infarction, any revascularization, and stroke at 1 year. This was mainly driven by reduced repeat revascularization.
Corresponding Author: To contact the corresponding author, Tobias F. S. Pustjens, MD, email t.pustjens@gmail.com.
To access the embargoed study: Visit our For The Media website at this link ...
Participation of women in cardiovascular trials from 2017 to 2023
2025-08-31
About The Study: The findings of this study highlight both progress and persistent challenges in representation of women within cardiovascular trials. These gaps not only limit the generalizability of trial outcomes but also perpetuate inequities in evidence-based care for women with cardiovascular conditions.
Corresponding Author: To contact the corresponding author, Martha Gulati, MD, MS, email martha.gulati@csmc.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
Editor’s Note: Please see the article for ...
LAST 30 PRESS RELEASES:
Black adults face heart failure nearly 14 years earlier than white patients
Study detects multidrug-resistant KPC-producing bacteria in Chilean wastewater for the first time
New artificial intelligence model accurately identifies which atrial fibrillation patients need blood thinners to prevent stroke
Safety of factor XI inhibition with abelacimab in atrial fibrillation by kidney function
Combination of mini-camera and AI predicts recurrent heart attack
Study Reveals Details of Overactive Immune System in Patients with Chronic Fatigue Syndrome (ME/CFS)
UTSA and UT Health San Antonio complete merger to become The University of Texas at San Antonio
Helicobacter pylori screening after acute myocardial infarction
Solar Orbiter traces superfast electrons back to Sun
GaN-based electron beam technology from Nagoya University startup poised to overcome critical semiconductor manufacturing challenges at KIOXIA
Circle versus rectangle: Finding ‘Earth 2.0’ may be easier using a new telescope shape
Metformin changes blood metal levels in humans
Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation
Fractional flow reserve–guided complete vs culprit-only revascularization in non–ST-elevation myocardial infarction and multivessel disease
Participation of women in cardiovascular trials from 2017 to 2023
Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction
Changes in biology of internal fat may be the leading cause of heart failure
Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk
Promising new drug for people with stubborn high blood pressure
One shot of RSV vaccine effective against hospitalization in older adults for two seasons
Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults
Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis
Risk of myocarditis or pericarditis with high-dose vs standard-dose influenza vaccine
High-dose vs standard-dose influenza vaccine and cardiovascular outcomes in older adults
Prevalence, determinants, and time trends of cardiovascular health in the WHO African region
New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers
CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients
Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock
Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes
High Mountain Asia’s shrinking glaciers linked to monsoon changes
[Press-News.org] Combination of mini-camera and AI predicts recurrent heart attackAI rapidly assesses coronary arteries for vulnerable spots